Roche: 2% growth in sales at constant exchange rates in Q1

(CercleFinance.com) - Roche reports sales of 14.
4bn CHF for Q1 2024, down 6% as reported, although up 2% at constant exchange rates, driven by strong growth in new drugs and diagnostics.

Excluding Covid-19-related products, sales rose by 7%, the Swiss healthcare group says, adding that going forward, there will be no further significant impact from the decline in Covid-19-related sales.

Roche is therefore confident of achieving mid-single digit sales growth this year (at constant exchange rates), and confirms its outlook for 2024.


Copyright (c) 2024 CercleFinance.com. All rights reserved.